Twin Tree Management
CORT icon

Twin Tree Management’s Corcept Therapeutics CORT Stock Holding History

Twin Tree Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150
Closed -$11K – 1515
2025
Q2 		$11K Sell
150
-46,720
-100% -$3.39M ﹤0.01% 1540
2025
Q1 		$5.35M Buy
46,870
+40,798
+672% +$2.48M 0.01% 881
2024
Q4 		$306K Buy
+6,072
New +$318K ﹤0.01% 1373

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Twin Tree Management's CORT Position: Q3 2025 in Review

Twin Tree Management sold out of Corcept Therapeutics (CORT) in Q3 2025, closing a stake of 150 shares — an estimated $11K sold.

Twin Tree Management first reported a position in CORT in Q4 2024 and held it in 3 quarters. The position peaked at $5.35M in Q1 2025. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Twin Tree Management reported no remaining Corcept Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Twin Tree Management sold 150 Corcept Therapeutics shares in Q3 2025, an estimated $11K.
  • Twin Tree Management first reported a position in Corcept Therapeutics in Q4 2024 and held it in 3 quarters.
  • Twin Tree Management's Corcept Therapeutics position peaked at $5.35M in Q1 2025.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Twin Tree Management's 13F filing for Q3 2025, filed 13 Nov 2025.